title: Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease.
abstract: This is a unique report of two cases of patients with end-stage renal disease on hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity of safety and efficacy data in this patient subgroup.
authors: Department of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA.
authors: Ludimila
authors: L
authors: Cavalcante
authors: Levine Cancer Institute, Charlotte, NC, USA.
authors: Asim
authors: A
authors: Amin
authors: Department of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA.
authors: Jose
authors: J
authors: Lutzky
keywords: advanced melanoma; hemodialysis; report of cases
references: N Engl J Med. 2009 Jul 9;361(2):211-2
references: 19587352
references: Eur J Cancer. 2012 Jan;48(2):237-42
references: 22030452
references: Eur J Cancer. 2012 Oct;48(15):2375-90
references: 22981501
references: N Engl J Med. 2010 Aug 19;363(8):711-23
references: 20525992
references: N Engl J Med. 2011 Jun 30;364(26):2517-26
references: 21639810
references: Clin Cancer Res. 2012 Apr 1;18(7):2039-47
references: 22271879
references: Anticancer Res. 2012 Oct;32(10 ):4607-8
references: 23060594
references: PLoS One. 2013;8(1):e53745
references: 23341990